Compare FEMY & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEMY | MDRR |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.9M | 18.2M |
| IPO Year | 2021 | N/A |
| Metric | FEMY | MDRR |
|---|---|---|
| Price | $0.38 | $11.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 1.2K |
| Earning Date | 05-08-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 2.43% |
| EPS Growth | ★ 44.71 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $2,293,313.00 | N/A |
| Revenue This Year | $105.16 | N/A |
| Revenue Next Year | $200.23 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.77 | N/A |
| 52 Week Low | $0.31 | $9.47 |
| 52 Week High | $1.11 | $14.52 |
| Indicator | FEMY | MDRR |
|---|---|---|
| Relative Strength Index (RSI) | 46.47 | 50.04 |
| Support Level | $0.34 | $11.00 |
| Resistance Level | $0.46 | $11.91 |
| Average True Range (ATR) | 0.04 | 0.26 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 24.29 | 77.20 |
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.